Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05227664 | A Study of AK117/AK112 in Metastatic Triple-Negative Breast Cancer | active not recruiting | Phase 2 | 120 | AkesoINDUSTRY | 1 | Mar 16, 2026 | clinicaltrials |
| NCT05697146 | Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in France(RosaLEE) | active not recruiting | — | 1,019 | Novartis PharmaceuticalsINDUSTRY | 1 | Mar 16, 2026 |
| clinicaltrials |
| NCT02712723 | Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer(FELINE) | active not recruiting | Phase 2 | 121 | Qamar KhanOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT05926024 | Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment | active not recruiting | — | 253 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT00367666 | Using Diagnostic Tools to Stage Breast Cancer | active not recruiting | N/A | 400 | University of PennsylvaniaOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT02567669 | Muscle Loss and Fatigue as a Consequence of Radiotherapy(MUSFAT) | active not recruiting | — | 20 | Essentia HealthOTHER | 0 | Mar 10, 2026 | clinicaltrials |
| NCT03619083 | Assessment of Sensory Gating, Attention, and Executive Control in Breast Cancer | active not recruiting | — | 187 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT04454528 | BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy(BreastVAX) | active not recruiting | Phase 1 / Phase 2 | 27 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT05810870 | PIK3CA/PTEN-altered Advanced Breast Cancer Treated With MEN1611 Monotherapy or in Combination With Eribulin(SABINA) | active not recruiting | Phase 2 | 14 | MedSIROTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT04085510 | Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western Pennsylvania(TOCEM) | active not recruiting | N/A | 1,647 | Wendie BergOTHER | 1 | Mar 9, 2026 | clinicaltrials |
| NCT05573555 | TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B) | active not recruiting | Phase 1 / Phase 2 | 20 | PfizerINDUSTRY | 4 | Mar 9, 2026 | clinicaltrials |
| NCT01928589 | Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer | active not recruiting | N/A | 81 | Richard ZellarsOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT03384914 | Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer | active not recruiting | Phase 2 | 119 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT00616967 | Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer | active not recruiting | Phase 2 | 68 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT01349322 | Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery | active not recruiting | Phase 3 | 2,354 | Radiation Therapy Oncology GroupNETWORK | 8 | Mar 5, 2026 | clinicaltrials |
| NCT04474834 | Genetic Risk Estimations for Influencing Decision Making in Women at High Risk of Breast Cancer, GENRE 2 Study(GENRE2) | active not recruiting | — | 737 | Mayo ClinicOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT04507568 | The Person-centered Evolution of Radiotherapy Services in Ontario Study(PERSON) | active not recruiting | N/A | 109 | University Health Network, TorontoOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT03238976 | Nature Sounds as a Pain and Anxiety Reducing Strategy in Patients Undergoing Breast Core Biopsy | active not recruiting | N/A | 200 | University of ChicagoOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT03386617 | AKY15-HK-301_NEPA Study | active not recruiting | Phase 2 | 55 | Chinese University of Hong KongOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT03846167 | Imaging of Primary or Recurrent Breast Cancer With 18F-FluorThanatrace PET/CT(FTT 2) | active not recruiting | — | 50 | University of PennsylvaniaOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT07447544 | Predictive Factors for CNS Metastases in Early Breast Cancer Using Liquid Biopsy (AKRA CŽS)(AKRA CŽS) | active not recruiting | N/A | 22 | Institute of Oncology LjubljanaOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT03164486 | First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide | active not recruiting | Early Phase 1 | 27 | Julie L. Sutcliffe, Ph.DOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT03272334 | Her2-BATS and Pembrolizumab in Metastatic Breast Cancer(Breast-47) | active not recruiting | Phase 1 / Phase 2 | 22 | University of VirginiaOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT04270149 | Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer | active not recruiting | Phase 1 | 8 | Herbert LyerlyOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT05294016 | Smart Bra for Diagnosing Breast Cancer(CBRA) | active not recruiting | N/A | 70 | Hopital Nord Franche-ComteOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT05755984 | 3D Printed Breast Models in the Surgical Management of Breast Cancer | active not recruiting | N/A | 20 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT07421141 | De-escalation of Neoadjuvant Treatment (Paclitaxel + HP) in Early HER2+ Breast Cancer(Opti-HER2) | active not recruiting | Phase 2 | 186 | National Medical Research Radiological Centre of the Ministry of Health of RussiaOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT04897009 | Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Operable Breast Cancer(ENHANCE) | active not recruiting | — | 38 | Mayo ClinicOTHER | 1 | Feb 25, 2026 | clinicaltrials |
| NCT02778685 | Pembrolizumab, Endocrine Therapy, and Palbociclib in Treating Postmenopausal Patients With Newly Diagnosed Metastatic Stage IV Estrogen Receptor Positive Breast Cancer | active not recruiting | Phase 2 | 47 | City of Hope Medical CenterOTHER | 1 | Feb 24, 2026 | clinicaltrials |
| NCT03414970 | Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer | active not recruiting | Phase 3 | 898 | Alliance for Clinical Trials in OncologyOTHER | 2 | Feb 24, 2026 | clinicaltrials |
| NCT05720039 | Robotic vs. Open NSM for Early Stage Breast Cancer(SP NSM) | active not recruiting | N/A | 204 | Intuitive SurgicalINDUSTRY | 1 | Feb 24, 2026 | clinicaltrials |
| NCT07428655 | Acceptability and Feasibility of PSC Model of Serious Illness Communication | active not recruiting | N/A | 28 | National Cancer Centre, SingaporeOTHER | 1 | Feb 24, 2026 | clinicaltrials |
| NCT07428720 | Axillary Lymph Node Changes After Neoadjuvant Therapy In Breast Cancer | active not recruiting | N/A | 97 | Institute of Oncology LjubljanaOTHER | 1 | Feb 24, 2026 | clinicaltrials |
| NCT00548236 | The Active After Cancer Trial (AACT)(AACT) | active not recruiting | N/A | 120 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 23, 2026 | clinicaltrials |
| NCT03641755 | Olaparib + Sapacitabine in BRCA Mutant Breast Cancer | active not recruiting | Phase 1 | 10 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 23, 2026 | clinicaltrials |
| NCT05587972 | Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Monitoring | active not recruiting | N/A | 100 | Carevive Systems, Inc.INDUSTRY | 1 | Feb 23, 2026 | clinicaltrials |
| NCT03523546 | Oncology Episode Payment Model in Hawaii | active not recruiting | N/A | 7 | University of PennsylvaniaOTHER | 1 | Feb 20, 2026 | clinicaltrials |
| NCT03978663 | Three Fraction Radiation to Induce Immuno-Oncologic Response(TRIO) | active not recruiting | N/A | 40 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Feb 20, 2026 | clinicaltrials |
| NCT04258813 | Onco-primary Care Networking to Support TEAM-based Care(ONE TEAM) | active not recruiting | N/A | 313 | Duke UniversityOTHER | 1 | Feb 20, 2026 | clinicaltrials |
| NCT05488483 | A Study of Tumor Imaging With Multispectral Optoacoustic Tomography | active not recruiting | — | 12 | Memorial Sloan Kettering Cancer CenterOTHER | 2 | Feb 19, 2026 | clinicaltrials |
| NCT05703399 | Long Term Followup of Patients Enrolled in MC1137, BEAUTY Study | active not recruiting | — | 140 | Mayo ClinicOTHER | 1 | Feb 19, 2026 | clinicaltrials |
| NCT07421479 | Patient-Derived Breast Cancer Organoids for Therapeutic Extracellular Vesicle Isolation (PDO-Mercurial01)(PDO-Mercurial) | active not recruiting | — | 50 | Istituti Clinici Scientifici Maugeri SpAOTHER | 1 | Feb 19, 2026 | clinicaltrials |
| NCT04176848 | CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer | active not recruiting | Phase 2 | 15 | Canadian Cancer Trials GroupNETWORK | 1 | Feb 18, 2026 | clinicaltrials |
| NCT02157051 | Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer | active not recruiting | Phase 1 | 42 | University of WashingtonOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT05316324 | A Study of the Use of Acellular Dermal Matrix for Breast Reconstruction | active not recruiting | Phase 3 | 353 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT06756802 | Reproductive Health in Breast Cancer Survivor(ISIS) | active not recruiting | — | 22,000 | Institut Cancerologie de l'OuestOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07407244 | Immune Tumor Stroma Factors and Pathologic Complete Response After Neoadjuvant Chemotherapy in Early Breast Cancer(AKRA) | active not recruiting | N/A | 268 | Institute of Oncology LjubljanaOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT02226276 | Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer | active not recruiting | N/A | 10 | City of Hope Medical CenterOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT03400215 | Gradient-Echo Spectroscopic Imaging Study of Saturated Fat and Breast Cancer | active not recruiting | N/A | 190 | NYU Langone HealthOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT04303715 | No Axillary sUrgical Treatment In Clinically Lymph Node Negative Patients After UltraSonography | active not recruiting | N/A | 1,734 | Seoul National University HospitalOTHER | 1 | Feb 13, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Mar 16, 2026source: clinicaltrials